O-(D-glucopyranosylidene)amino-Z-N-1-Dodecylcarbamate

ID: ALA3786086

Chembl Id: CHEMBL3786086

PubChem CID: 127031612

Max Phase: Preclinical

Molecular Formula: C19H37N3O6

Molecular Weight: 403.52

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCCNC(=O)O/N=C1\N[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

Standard InChI:  InChI=1S/C19H37N3O6/c1-2-3-4-5-6-7-8-9-10-11-12-20-19(27)28-22-18-17(26)16(25)15(24)14(13-23)21-18/h14-17,23-26H,2-13H2,1H3,(H,20,27)(H,21,22)/t14-,15-,16+,17-/m1/s1

Standard InChI Key:  MVLYQBOMBXUKDT-WCXIOVBPSA-N

Alternative Forms

  1. Parent:

    ALA3786086

    ---

Associated Targets(Human)

GBA1 Tclin Beta-glucocerebrosidase (14647 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

agl1 Alpha-glucosidase (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
lacZ Beta-galactosidase (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Alpha-galactosidase (362 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 403.52Molecular Weight (Monoisotopic): 403.2682AlogP: 0.99#Rotatable Bonds: 13
Polar Surface Area: 143.64Molecular Species: NEUTRALHBA: 7HBD: 6
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.43CX Basic pKa: 1.82CX LogP: 1.56CX LogD: 1.56
Aromatic Rings: Heavy Atoms: 28QED Weighted: 0.15Np Likeness Score: 0.51

References

1. Wang J, Wang X, Zhao Y, Ma X, Wan Y, Chen Z, Chen H, Gan H, Li J, Li L, Wang PG, Zhao W.  (2016)  Synthesis and biological evaluation ofd-gluconhydroximo-1,5-lactam and its oxime-substituted derivatives as pharmacological chaperones for the treatment of Gaucher disease,  (2): [10.1039/C5MD00501A]

Source